Emerald Group Publishing

Emerald Health Therapeutics Appoints Moe Jiwan as Chief Operating Officer

Tuesday, May 4, 2021 - 12:00pm

b'Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald")\xc2\xa0has appointed Mr. Moe Jiwan as Chief Operating Officer effective May 10th.\nMr.

Key Points: 
  • b'Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald")\xc2\xa0has appointed Mr. Moe Jiwan as Chief Operating Officer effective May 10th.\nMr.
  • Before joining Emerald, he served in senior leadership positions, including chief information officer and chief customer officer, for established cannabis and health companies, including senior roles at TerrAscend Corp and Shopper\'s Drug Mart.
  • We wish them the best in their new endeavors," said Mr. Riaz Bandali, President & Chief Executive Officer of Emerald.
  • Moe has a well-rounded perspective on the strategy and execution necessary for the next phase of Emerald\'s redefined growth plan.

Emerald Health Therapeutics Promotes Two Executives to Senior Roles

Friday, February 5, 2021 - 12:00pm

Vancouver, British Columbia--(Newsfile Corp. - February 5, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has promoted Orville Bovenschen to the position of Senior Vice President, Operations and Rebecca Wong to Senior Vice President, Quality & Regulatory Affairs.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - February 5, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has promoted Orville Bovenschen to the position of Senior Vice President, Operations and Rebecca Wong to Senior Vice President, Quality & Regulatory Affairs.
  • With Emerald since 2017, he has overseen the planning and management of all construction and facility development projects.
  • Prior to that he served in various management roles for Strukton, the fourth largest engineering and construction company in the Netherlands.
  • Emerald undertakes no obligations to update or revise such statements to reflect new circumstances or unanticipated events as they occur, unless required by applicable law.

DGP Capital Advises Veris Manufacturing On Its Sale to New Water Capital Portfolio Company Emerald EMS

Tuesday, December 1, 2020 - 8:12pm

BREA, Calif., Dec. 1, 2020 /PRNewswire/ -- DGP Capital LLC is pleased to announce the acquisition of Veris Manufacturing ("Veris"), by Emerald Electronic Manufacturing Services ("Emerald EMS" or "Emerald").

Key Points: 
  • BREA, Calif., Dec. 1, 2020 /PRNewswire/ -- DGP Capital LLC is pleased to announce the acquisition of Veris Manufacturing ("Veris"), by Emerald Electronic Manufacturing Services ("Emerald EMS" or "Emerald").
  • Emerald EMS is a portfolio company of the private equity firm New Water Capital ( www.newwatercapital.com ).
  • Veris Manufacturing ( www.verismfg.com ) is a full-service contract manufacturer headquartered in Brea, California, specializing in the advanced manufacturing of electronic assemblies.
  • Jack Chang, Managing Director of DGP Capital, commented, "The team at DGP Capital is honored to have represented Veris on its transaction with Emerald and the New Water Capital team.

GrowGeneration Corp. Acquires Concord, CA Based Emerald City Garden

Tuesday, August 11, 2020 - 1:00pm

DENVER, Aug. 11, 2020 /PRNewswire/ - GrowGeneration Corp. (NASDAQ: GRWG), ("GrowGen"or the "Company") the largest chain of specialty hydroponic and organic garden centers, with currently 27 locations,is pleased to announce that the company has purchased the assets of Emerald City Garden located in Concord, CA.

Key Points: 
  • DENVER, Aug. 11, 2020 /PRNewswire/ - GrowGeneration Corp. (NASDAQ: GRWG), ("GrowGen"or the "Company") the largest chain of specialty hydroponic and organic garden centers, with currently 27 locations,is pleased to announce that the company has purchased the assets of Emerald City Garden located in Concord, CA.
  • With the acquisition of Emerald City Garden, GrowGen opens up the East Bay region.
  • Emerald City Garden has been in business since 2012 and is one of the largest hydroponic operations in the region, with 2020 sales estimated to be approximately $4.0 million.
  • Darren Lampert, GrowGeneration CEO stated, "The Emerald City Garden acquisition is our 3rd in 2020,adding a strong team and customer base to our portfolio of hydroponic garden centers.

Emerald Health Therapeutics Terminates Consulting and Loan Agreements

Thursday, July 16, 2020 - 2:04am

VANCOUVER, July 15, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (Emerald) (TSXV: EMH; OTCQX: EMHTF) has terminated certain related party agreements pertaining to consulting services and a loan facility.

Key Points: 
  • VANCOUVER, July 15, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (Emerald) (TSXV: EMH; OTCQX: EMHTF) has terminated certain related party agreements pertaining to consulting services and a loan facility.
  • Emerald Health Sciences Inc. ("EHS"), a control person of Emerald, and Emerald entered into an independent contractor agreement on May 1, 2015, as amended from time to time (the Consulting Agreement), and a loan agreement on August 25, 2015, as amended from time to time (the Loan Agreement).
  • We are very pleased with our progress to systematically rationalize, restructure and/or terminate agreements, in order to only focus on initiatives that will provide commercial and financial value to Emerald Health Therapeutics in the future, said Riaz Bandali, President and CEO of Emerald.
  • After the termination of these three agreements, Emerald Health Therapeutics has only one remaining related-party agreement with an Emerald Health Sciences entity.

Emerald Digital Named Top Advertising Firm in New Orleans

Thursday, June 18, 2020 - 7:04pm

Emerald Digital , a full-service digital marketing firm with offices in New Orleans and New York City, is pleased to announce that it has been named a top advertising agency in New Orleans by Expertise.com.

Key Points: 
  • Emerald Digital , a full-service digital marketing firm with offices in New Orleans and New York City, is pleased to announce that it has been named a top advertising agency in New Orleans by Expertise.com.
  • Emerald Digital has had an exceptional year so far with the launch of The Law Center, a national network of top law firms, said Warren H. Cohn, CEO of Emerald Digital.
  • I am so proud of the Emerald Digital team and the work that we have accomplished, said Matthew Berman, President of Emerald Digital.
  • Emerald Digital is a digital marketing agency that specializes in targeted advertising through PPC campaigns, public relations, SEO, and social media advertising.

Emerald Health Therapeutics Reports Year-end and Fourth Quarter 2019 Financial Results and Provides Corporate Update

Thursday, May 14, 2020 - 12:00pm

In the fourth quarter, Emerald received its Health Canada cultivation license amendment and organic certification for its organic cannabis operation in Metro Vancouver.

Key Points: 
  • In the fourth quarter, Emerald received its Health Canada cultivation license amendment and organic certification for its organic cannabis operation in Metro Vancouver.
  • In the fourth quarter, Emerald fulfilled its first shipment of premium cannabis products to the Nova Scotia Liquor Corporation for the adult-use market.
  • In 2019, Emerald appointed Mr. Riaz Bandali as President and CEO and Ms. Jenn Hepburn, previously Director, Finance, as Chief Financial Officer and Corporate Secretary.
  • Emerald Health Therapeutics will host a conference call on Thursday, May 14, 2020 at 10:30 a.m.

Emerald Health Therapeutics Extends Dates for Filing Financial Statements

Wednesday, April 29, 2020 - 11:35pm

VANCOUVER, April 29, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (Emerald) (TSXV: EMH; OTCQX: EMHTF) announces that as a result of the COVID-19 pandemic, Emerald, as well as its auditors and filing agents, have followed the recommendations of local health authorities and temporarily closed their offices, having employees work remotely to minimize their exposure risk.

Key Points: 
  • VANCOUVER, April 29, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (Emerald) (TSXV: EMH; OTCQX: EMHTF) announces that as a result of the COVID-19 pandemic, Emerald, as well as its auditors and filing agents, have followed the recommendations of local health authorities and temporarily closed their offices, having employees work remotely to minimize their exposure risk.
  • Emerald confirms that there have been no material developments, other than those disclosed through news releases, since the filing of its interim consolidated financial statements for the period ended September 30, 2019.
  • Emerald Health Therapeutics, Inc. is committed to cutting-edge cannabis science to create new consumer experiences with distinct recreational, medical and wellness-oriented cannabis and non-cannabis products.
  • Emerald undertakes no obligations to update or revise such statements to reflect new circumstances or unanticipated events as they occur, unless required by applicable law.

Emerald Holding, Inc. Announces Temporary Suspension of Quarterly Dividend

Friday, March 20, 2020 - 1:00pm

The Board of Directors will re-assess the dividend suspension throughout the year to determine, in light of facts and circumstances at that time, whether and when to reinstate the dividend.

Key Points: 
  • The Board of Directors will re-assess the dividend suspension throughout the year to determine, in light of facts and circumstances at that time, whether and when to reinstate the dividend.
  • Taken together, we believe these are the right actions to position Emerald to successfully weather this challenging environment.
  • Emerald is a leader in building dynamic, market-driven business-to-business platforms that integrate live events with a broad array of industry insights, digital tools, and data-focused solutions to create uniquely rich experiences.
  • As true partners, we at Emerald strive to build our customers businesses by creating opportunities that inspire, amaze, and deliver breakthrough results.

Emerald Health Therapeutics Closes Final Tranche Prospectus Sale

Saturday, February 15, 2020 - 3:11am

VANCOUVER, British Columbia, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (Emerald) (TSXV: EMH; OTCQX: EMHTF) has closed the final tranche of its $3,000,000 prospectus offering (the Offering), announced in its news release dated January 6, 2020.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (Emerald) (TSXV: EMH; OTCQX: EMHTF) has closed the final tranche of its $3,000,000 prospectus offering (the Offering), announced in its news release dated January 6, 2020.
  • Pursuant to this final closing, Emerald has issued an aggregate of 2,748,276 units of Emerald (each, a "Unit") at a price of $0.29 per Unit for total gross proceeds of $797,000.
  • Each Unit consists of one common share of Emerald and one common share purchase warrant (each, a "Warrant").
  • Emerald Health Therapeutics, Inc. is committed to creating new consumer experiences with recreational and wellness-oriented cannabis products.